NASDAQ:MEIP
MEI Pharma Stock News
$3.10
-0.160 (-4.91%)
At Close: Apr 25, 2024
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
07:16pm, Tuesday, 13'th Feb 2024
MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $1.66 per share versus the Zacks Consensus Estimate of a loss of $1.46. This compares to earnings of $1.60 per share a year ago.
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
05:00pm, Tuesday, 16'th Jan 2024
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer
All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
01:32pm, Friday, 29'th Sep 2023
MEI Pharma, Inc. (MEIP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
07:47pm, Tuesday, 26'th Sep 2023
MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2023 Earnings Call Transcript September 26, 2023 5:00 PM ET Company Participants David Walsey - SVP, Corporate Affairs David Urso - President & CEO Jay File - CFO Ri
SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity Pharmace
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
07:02pm, Thursday, 11'th May 2023
MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $2.60. This compares to loss of $3.40 per share a year ago.
MEI Pharma, Inc. (MEIP) Q2 Earnings and Revenues Top Estimates
07:35pm, Thursday, 09'th Feb 2023
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 150% and 237.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimates
06:48pm, Monday, 14'th Nov 2022
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 10.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
MEI Pharma, Inc. (MEIP) Q4 2022 Earnings Call Transcript
09:00pm, Thursday, 08'th Sep 2022
MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2022 Results Conference Call September 8, 2022 5:00 PM ET Company Participants David Walsey - Senior Vice President and Corporate Affairs Dan Gold - President and Ch
Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List
08:34pm, Friday, 17'th Jun 2022 PennyStocks
Can these penny stocks continue to make gains
The post Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List
04:34pm, Friday, 17'th Jun 2022
Can these penny stocks continue to make gains The post Best Penny Stocks to Buy Right Now? 3 For Your Mid-June List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com
Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now
11:20pm, Thursday, 09'th Jun 2022 PennyStocks
Biotech penny stocks to watch in June.
The post Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now
07:20pm, Thursday, 09'th Jun 2022
Biotech penny stocks to watch in June. The post Top Penny Stocks To Buy?
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
09:35pm, Monday, 23'rd May 2022 Zacks Investment Research
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 55.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
06:49pm, Monday, 23'rd May 2022
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 55.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?